We Are Not Ready to Edit Human Embryos Yet
By J. Craig Venter,
Time
| 02. 02. 2016
Untitled Document
Unless we have sufficient knowledge and wisdom we should not proceed
Discussions on human genome modifications to eliminate disease genes and/or for human enhancement are not new and have been common place since the first discussions on sequencing the human genome occurred in the mid 1980’s. Many a bioethicist has made their careers from such discussions, and currently on Amazon there are dozens of books on a wide range of human enhancement topics including those that predict that editing our genes will lead to the end of humanity. There are also thousands of news stories on the new DNA editing tools called CRISPR.
So why is genome editing so different? If we can use CRISPR techniques to change the letters of the genetic code known to be associated with rare genetic disorders such as Tay-Sachs disease, Huntington’s disease, cystic fibrosis, cycle cell anemia or ataxia telangiectasia, why wouldn’t we just do so and eliminate the diseases from human existence? The answer is both simple and complex at the same time: just because the techniques have become easier to...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
